{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05847790",
            "orgStudyIdInfo": {
                "id": "852291"
            },
            "organization": {
                "fullName": "University of Pennsylvania",
                "class": "OTHER"
            },
            "briefTitle": "Remote Pregnancy Monitoring to Improve Access",
            "officialTitle": "Remote Pregnancy Monitoring to Improve Access: The REACTIVE Trial",
            "acronym": "REACTIVE",
            "therapeuticArea": [
                "Other"
            ],
            "study": "remote-pregnancy-monitoring-to-improve-access"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-25",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-05",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-05",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-04-27",
            "studyFirstSubmitQcDate": "2023-04-27",
            "studyFirstPostDateStruct": {
                "date": "2023-05-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-30",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Samuel Parry, MD",
                "investigatorTitle": "Professor of OBGYN",
                "investigatorAffiliation": "University of Pennsylvania"
            },
            "leadSponsor": {
                "name": "University of Pennsylvania",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this clinical trial is to determine the effectiveness of remote nonstress test (NST) compared to in-clinic NSTs in improving fetal testing completion rates. Participants will be randomized to either in-clinic NSTs or use of an FDA-approved remote monitoring belt for their pregnancy monitoring."
        },
        "conditionsModule": {
            "conditions": [
                "Fetal Monitoring"
            ],
            "keywords": [
                "Fetal monitoring",
                "antenatal testing"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 400,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Remote NST",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Device: Invu monitoring belt"
                    ]
                },
                {
                    "label": "In-clinic NST - Standard of Care",
                    "type": "ACTIVE_COMPARATOR",
                    "interventionNames": [
                        "Other: Standard of care"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Invu monitoring belt",
                    "description": "INVU monitoring belt used for remote NSTs",
                    "armGroupLabels": [
                        "Remote NST"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Standard of care",
                    "description": "In-clinic NSTs - standard of care",
                    "armGroupLabels": [
                        "In-clinic NST - Standard of Care"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Overall Fetal Testing Completion Rate",
                    "description": "percentage of recommended antenatal testing sessions that were successfully completed as defined as a clinically interpreted test was performed",
                    "timeFrame": "from 32 weeks gestational age to delivery, average of 10 weeks after enrollment."
                },
                {
                    "measure": "Fetal Testing Completion Rate in Black versus non-Black subjects",
                    "description": "Comparison between Black and non-Black subjects' percentage of recommended antenatal testing sessions that were successfully completed as defined as a clinically interpreted test was performed.",
                    "timeFrame": "from 32 weeks gestational age to delivery, average of 10 weeks after enrollment."
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Fetal Monitoring outcomes: Number of visits to the antenatal testing unit",
                    "description": "Count of visits to the office for in-person monitoring",
                    "timeFrame": "from 32 weeks gestational age to delivery, average of 10 weeks after enrollment."
                },
                {
                    "measure": "Fetal Monitoring outcomes: Frequency of provider recommended prolonged monitoring",
                    "description": "Count of number of times provider recommends prolonged monitoring (defined by greater than 40 minutes of time on the monitor).",
                    "timeFrame": "from 32 weeks gestational age to delivery, average of 10 weeks after enrollment."
                },
                {
                    "measure": "Fetal Monitoring outcomes: Time on NST monitor",
                    "description": "Sum of the number of minutes the subject is on the NST monitor",
                    "timeFrame": "from 32 weeks gestational age to delivery, average of 10 weeks after enrollment."
                },
                {
                    "measure": "Fetal Monitoring outcomes: Number of non-reactive NSTs",
                    "description": "Count of the number of visits",
                    "timeFrame": "from 32 weeks gestational age to delivery, average of 10 weeks after enrollment."
                },
                {
                    "measure": "Fetal Monitoring outcomes: Number of biophysical profiles performed for non-reactive NST tests",
                    "description": "Count of the number of biophysical profiles performed for non-reactive NST visits",
                    "timeFrame": "from 32 weeks gestational age to delivery, average of 10 weeks after enrollment."
                },
                {
                    "measure": "Fetal Monitoring outcomes: Overall number of visits to the obstetrical triage unit",
                    "description": "Count of the number of visits to the obstetrical triage unit",
                    "timeFrame": "from 32 weeks gestational age to delivery, average of 10 weeks after enrollment."
                },
                {
                    "measure": "Fetal Monitoring outcomes: Overall number of visits to the obstetrical triage unit directly related to a fetal monitoring visit",
                    "description": "Count of the number of visit directly related to an outpatient fetal monitoring appointment or session",
                    "timeFrame": "from 32 weeks gestational age to delivery, average of 10 weeks after enrollment."
                },
                {
                    "measure": "Fetal Monitoring outcomes: Frequency of recommendation for delivery based on findings on fetal monitoring result",
                    "description": "Count of the number of subjects in each arm who receive a recommendation for delivery based on the findings of the fetal monitoring results.",
                    "timeFrame": "from 32 weeks gestational age to delivery, average of 10 weeks after enrollment."
                },
                {
                    "measure": "Fetal Monitoring outcomes: Number of times a NST is not completed within the prescribed window",
                    "description": "Count of number of NSTs which occur outside of prescribed window, for example, if a weekly testing regimen is prescribed, an appointment 8 or more days following the last one would count as 1 missed calendar window.",
                    "timeFrame": "from 32 weeks gestational age to delivery, average of 10 weeks after enrollment."
                },
                {
                    "measure": "Obstetrics outcomes: Gestational age at delivery",
                    "description": "gestational age at time of delivery",
                    "timeFrame": "time of delivery"
                },
                {
                    "measure": "Obstetrics outcomes: Number of participants with Preterm delivery",
                    "description": "preterm delivery is defined as less than 37 weeks gestational age",
                    "timeFrame": "time of delivery"
                },
                {
                    "measure": "Obstetrics outcomes: Mode of delivery",
                    "description": "categorized as vaginal or cesarean",
                    "timeFrame": "time of delivery"
                },
                {
                    "measure": "Obstetrics outcomes: Number of participants with an Indication for labor induction",
                    "description": "in subjects who have labor induction, indication for inducing labor",
                    "timeFrame": "time of labor induction"
                },
                {
                    "measure": "Obstetrics outcomes: Number of participants with an Indication for cesarean section",
                    "description": "in subjects who have a cesarean section delivery, indication for cesarean section",
                    "timeFrame": "time of delivery"
                },
                {
                    "measure": "Obstetrics outcomes: Composite neonatal morbidity score",
                    "description": "Composite score of neonatal morbidity comprised of one or more of the following: severe respiratory distress, neonatal resuscitation outside of the delivery room, and death. This score could range from 0 to 3 with a higher score meaning a worse outcome",
                    "timeFrame": "from delivery to 6 weeks post-delivery"
                },
                {
                    "measure": "Obstetrics outcomes: Neonatal cord blood pH",
                    "timeFrame": "time of delivery"
                },
                {
                    "measure": "Obstetrics outcomes: Apgar scores",
                    "description": "Apgar score at five and ten minutes after delivery, the score ranges from 0 to 10 with a higher score meaning a better outcome.",
                    "timeFrame": "five and ten minutes after delivery"
                },
                {
                    "measure": "Obstetrics outcomes: Number of participants with an Admission to the neonatal intensive care unit",
                    "timeFrame": "from delivery to 6 weeks post-delivery"
                },
                {
                    "measure": "Obstetrics outcomes: Admission to the neonatal intensive care unit for greater than 48 hours",
                    "timeFrame": "from delivery to 6 weeks post-delivery"
                },
                {
                    "measure": "Obstetrics outcomes: Maternal length of stay",
                    "timeFrame": "from delivery to discharge, up to 6 weeks post-delivery"
                },
                {
                    "measure": "Obstetrics outcomes: Neonatal length of stay",
                    "timeFrame": "from birth to discharge, up to 6 weeks after birth"
                },
                {
                    "measure": "Cost-effectiveness outcomes: Productivity loss survey",
                    "description": "This survey will collect in half days increments the productivity impacts of the pregnancy, NSTs and for seeking health care for those reasons",
                    "timeFrame": "at three timepoints, at time of randomization, 3 weeks after randomization (plus or minus 1 week) and 5 weeks after randomization (plus or minus 1 week)"
                },
                {
                    "measure": "Cost-effectiveness outcomes: Costs",
                    "description": "Costs will be estimated based on collection of data on all health care visits, including outpatient, ED, OB triage and hospital admissions",
                    "timeFrame": "from 32 weeks to delivery, average of 10 weeks after enrollment."
                },
                {
                    "measure": "Implementation outcomes: Theory-informed Acceptability Questionnaire",
                    "description": "8-item Likert scale with range of values from 8 to 40 with a high score being more acceptable.",
                    "timeFrame": "at time of delivery"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Singleton pregnancy\n* Gestational age between 30 weeks 0 days and 35 weeks 6 days\n* Pregnant patients who have clinical indication for fetal surveillance with NSTs (based on UPHS Health System clinical guidelines for antenatal monitoring)\n* Able to provide written consent\n* English speaking\n\nExclusion Criteria:\n\n* Multiple gestations\n* Maternal pre-gravid BMI greater than 45kg/m2\n* Presence of an implanted pacemaker or defibrillator\n* Active abdominal skin infection\n* A known amniotic fluid index (AFI) less than 5cm or greater than 25cm on the most recent ultrasound (if available) prior to randomization\n* Delivery is planned within 2 weeks of potential randomization",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Samuel Parry, MD",
                    "role": "CONTACT",
                    "phone": "215-662-4789",
                    "email": "parry@pennmedicine.upenn.edu"
                },
                {
                    "name": "Meaghan McCabe, MPH",
                    "role": "CONTACT",
                    "phone": "215-349-5277",
                    "email": "meaghan.mccabe@pennmedicine.upenn.edu"
                }
            ],
            "locations": [
                {
                    "facility": "University of Pennsylvania",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Meaghan McCabe, MPH",
                            "role": "CONTACT",
                            "phone": "215-349-5277",
                            "email": "meaghan.mccabe@pennmedicine.upenn.edu"
                        },
                        {
                            "name": "Naeemah Turner, MSN",
                            "role": "CONTACT",
                            "phone": "215-275-2507",
                            "email": "naeemah.turner@pennmedicine.upenn.edu"
                        },
                        {
                            "name": "Samuel Parry, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}